Siegfried Holding AG - Company Profile
Powered by 
All the data and insights you need on Siegfried Holding AG in one report.
$295
- Save hours of research time and resources with
our up-to-date Siegfried Holding AG Strategy Report
- Understand Siegfried Holding AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Siegfried Holding AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Siegfried Holding AG's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Andreas Casutt, Ph.D.
Chairman Executive BoardDr. Andreas Casutt has been the Chairman of the board since March 2014. Prior to this, he served as a partner since 2012 and Managing Partner from 2006 to 2014 of Niederer Kraft and Frey law firm.
Wolfgang Wienand Ph.D.
Chief Executive Officer Senior ManagementDr. Wolfgang Wienand has been the Chief Executive Officer of Siegfried since January 2019. Previously, he served as the Head of Strategy, Mergers & Acquisitions, Legal and Intellectual Property Management and Regulatory Affairs. Dr. Wienand is also responsible for Siegfried’s global Research and Development activities since May 2017. Prior to joining Siegfried, he held senior management positions at Evonik Industries AG.
Reto Suter, Ph.D.
Chief Financial Officer Senior ManagementDr. Reto Suter has been the Chief Financial Officer of Siegfried since May 2017. Prior to this, he served as the Chief Operating Officer, Chief Information Officer and Board Member of Lonrho, a long-established company headquartered in London, the UK and Johannesburg, South Africa. He has held a range of responsible positions in industry and in finance and private equity in the past 16 years.
Jurgen Roos, Ph.D.
Chief Scientific Officer Senior ManagementMr. Jurgen Ross has been the Chief Scientific Officer of the company since April 2019. Prior to this, he served various management positions in R&D including Vice President Innovation Management of Nutrition and Business Unit; Head of Process Development in Exclusive Synthesis and Global Head of R&D of Healthcare Divison at Evonik Industries AG.
Marcel Imwinkelried
Chief Operating Officer - Drug Products Senior ManagementMr. Marcel Imwinkelried has been the Chief Operating Officer of Drug Products since October 2021. Previously, he served as Multi-Site Head for the drug products sites since January 2021. Prior to this, he served various management roles in Novartis.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer